Participating in a clinical trial
From a new vaccine through to treatments to manage cardiovascular conditions, diabetes, or Alzheimer’s; clinical studies play a vital role in transforming discoveries into treatments for patients and the broader community. By participating in one of our paid clinical trials, you play a real role in advancing medicine and improving lives.
You will be treated with the utmost care and supported every step of the way. You will also be reimbursed up to $360 per day for your time.
This is your chance to help make a real difference!
At Nucleus Network we run early-stage clinical trials for some of the world’s leading pharmaceutical and biotechnology companies.
Do you have questions about how clinical trials work and what it’s like to take part in one? Discover the Participant Journey or read our Frequently Asked Questions.
We are always happy to speak to potential participants at 1800 243 733.
Our Unique Offering
Nucleus Network is the only Phase 1 clinical research organization in the world to have Phase 1 facilities located in Australia and the USA. We are Australia’s largest Phase 1 clinical research organization and one of the few specialized units in the USA capable of delivering Phase 1 hepatic and renal clinical trials.
Nucleus Network is uniquely positioned to help administer your clinical trial with our four key advantages:
Specialization
Each of our Phase 1 facilities have focused areas of specialization and extensive internal and external capabilities to support the complex requirements of Phase 1 clinical trials.
Read More
Expertise
Our Phase 1 facilities are supported by a highly trained and dedicated team of medical personnel (FRACP), including clinical pharmacologists, oncologists, nephrologists and infectious disease physicians.
Read More
Location
Our Australian Phase 1 facilities are strategically co-located within prominent Hospitals and our USA Phase 1 facility benefits from co-locating within a Life Sciences and Biomedical Research Precinct.
Read More
Quality
The data generated from Nucleus Network is used to support IND and NDA regulatory filings for the USA FDA. Data is also used for EMA, PMDA and Health Canada regulatory filings.
Read MoreIn excess of
Phase 1 clinical trials conducted
More than
years’ experience conducting Phase 1 clinical trials
Over
Phase 1 clinical trial beds
Access to over
total population across Brisbane and Melbourne (Australia)
As well as
total population across Minneapolis – Saint Paul (USA)
Hosted over
sponsor audits, including FDA and EMA regulatory inspections
